773 related articles for article (PubMed ID: 23335968)
1. Fusobacterium is associated with colorectal adenomas.
McCoy AN; Araújo-Pérez F; Azcárate-Peril A; Yeh JJ; Sandler RS; Keku TO
PLoS One; 2013; 8(1):e53653. PubMed ID: 23335968
[TBL] [Abstract][Full Text] [Related]
2. Microbial mucosal colonic shifts associated with the development of colorectal cancer reveal the presence of different bacterial and archaeal biomarkers.
Mira-Pascual L; Cabrera-Rubio R; Ocon S; Costales P; Parra A; Suarez A; Moris F; Rodrigo L; Mira A; Collado MC
J Gastroenterol; 2015 Feb; 50(2):167-79. PubMed ID: 24811328
[TBL] [Abstract][Full Text] [Related]
3. [Quantitation of intestinal Fusobacterium and butyrate- producing bacteria in patients with colorectal adenomas and colorectal cancer].
Miao H; Wu N; Luan C; Yang X; Zhang R; Lv N; Zhu B
Wei Sheng Wu Xue Bao; 2014 Oct; 54(10):1228-34. PubMed ID: 25803901
[TBL] [Abstract][Full Text] [Related]
4. Fusobacterium nucleatum associates with stages of colorectal neoplasia development, colorectal cancer and disease outcome.
Flanagan L; Schmid J; Ebert M; Soucek P; Kunicka T; Liska V; Bruha J; Neary P; Dezeeuw N; Tommasino M; Jenab M; Prehn JH; Hughes DJ
Eur J Clin Microbiol Infect Dis; 2014 Aug; 33(8):1381-90. PubMed ID: 24599709
[TBL] [Abstract][Full Text] [Related]
5. Aspirin Modulation of the Colorectal Cancer-Associated Microbe Fusobacterium nucleatum.
Brennan CA; Nakatsu G; Gallini Comeau CA; Drew DA; Glickman JN; Schoen RE; Chan AT; Garrett WS
mBio; 2021 Apr; 12(2):. PubMed ID: 33824205
[TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of mucosal adherent bacteria and associations with colorectal adenomas.
Shen XJ; Rawls JF; Randall T; Burcal L; Mpande CN; Jenkins N; Jovov B; Abdo Z; Sandler RS; Keku TO
Gut Microbes; 2010; 1(3):138-47. PubMed ID: 20740058
[TBL] [Abstract][Full Text] [Related]
7. Evolutionary biologic changes of gut microbiota in an 'adenoma-carcinoma sequence' mouse colorectal cancer model induced by 1, 2-Dimethylhydrazine.
Sun T; Liu S; Zhou Y; Yao Z; Zhang D; Cao S; Wei Z; Tan B; Li Y; Lian Z; Wang S
Oncotarget; 2017 Jan; 8(1):444-457. PubMed ID: 27880935
[TBL] [Abstract][Full Text] [Related]
8. Gut microbiota signatures in tissues of the colorectal polyp and normal colorectal mucosa, and faeces.
Zhong X; Wang Y; Xu J; Cao H; Zhang F; Wang X
Front Cell Infect Microbiol; 2022; 12():1054808. PubMed ID: 36704106
[TBL] [Abstract][Full Text] [Related]
9. Association of plasma endotoxin, inflammatory cytokines and risk of colorectal adenomas.
Kang M; Edmundson P; Araujo-Perez F; McCoy AN; Galanko J; Keku TO
BMC Cancer; 2013 Feb; 13():91. PubMed ID: 23442743
[TBL] [Abstract][Full Text] [Related]
10. Increased rectal microbial richness is associated with the presence of colorectal adenomas in humans.
Sanapareddy N; Legge RM; Jovov B; McCoy A; Burcal L; Araujo-Perez F; Randall TA; Galanko J; Benson A; Sandler RS; Rawls JF; Abdo Z; Fodor AA; Keku TO
ISME J; 2012 Oct; 6(10):1858-68. PubMed ID: 22622349
[TBL] [Abstract][Full Text] [Related]
11.
Hussan H; Clinton SK; Roberts K; Bailey MT
World J Gastroenterol; 2017 Dec; 23(48):8626-8650. PubMed ID: 29358871
[TBL] [Abstract][Full Text] [Related]
12. Analysis of Mucosa-Associated Microbiota in Colorectal Cancer.
Xu K; Jiang B
Med Sci Monit; 2017 Sep; 23():4422-4430. PubMed ID: 28904330
[TBL] [Abstract][Full Text] [Related]
13. Enterotype-based Analysis of Gut Microbiota along the Conventional Adenoma-Carcinoma Colorectal Cancer Pathway.
Yang TW; Lee WH; Tu SJ; Huang WC; Chen HM; Sun TH; Tsai MC; Wang CC; Chen HY; Huang CC; Shiu BH; Yang TL; Huang HT; Chou YP; Chou CH; Huang YR; Sun YR; Liang C; Lin FM; Ho SY; Chen WL; Yang SF; Ueng KC; Huang HD; Huang CN; Jong YJ; Lin CC
Sci Rep; 2019 Jul; 9(1):10923. PubMed ID: 31358825
[TBL] [Abstract][Full Text] [Related]
14. Relationship between
Proença MA; Biselli JM; Succi M; Severino FE; Berardinelli GN; Caetano A; Reis RM; Hughes DJ; Silva AE
World J Gastroenterol; 2018 Dec; 24(47):5351-5365. PubMed ID: 30598580
[TBL] [Abstract][Full Text] [Related]
15. Mucosal adherent bacterial dysbiosis in patients with colorectal adenomas.
Lu Y; Chen J; Zheng J; Hu G; Wang J; Huang C; Lou L; Wang X; Zeng Y
Sci Rep; 2016 May; 6():26337. PubMed ID: 27194068
[TBL] [Abstract][Full Text] [Related]
16. Enrichment of Prevotella intermedia in human colorectal cancer and its additive effects with Fusobacterium nucleatum on the malignant transformation of colorectal adenomas.
Lo CH; Wu DC; Jao SW; Wu CC; Lin CY; Chuang CH; Lin YB; Chen CH; Chen YT; Chen JH; Hsiao KH; Chen YJ; Chen YT; Wang JY; Li LH
J Biomed Sci; 2022 Oct; 29(1):88. PubMed ID: 36303164
[TBL] [Abstract][Full Text] [Related]
17. Microbial Community Heterogeneity Within Colorectal Neoplasia and its Correlation With Colorectal Carcinogenesis.
Liu W; Zhang X; Xu H; Li S; Lau HC; Chen Q; Zhang B; Zhao L; Chen H; Sung JJ; Yu J
Gastroenterology; 2021 Jun; 160(7):2395-2408. PubMed ID: 33581124
[TBL] [Abstract][Full Text] [Related]
18. 16S rRNA of Mucosal Colon Microbiome and CCL2 Circulating Levels Are Potential Biomarkers in Colorectal Cancer.
Nardelli C; Granata I; Nunziato M; Setaro M; Carbone F; Zulli C; Pilone V; Capoluongo ED; De Palma GD; Corcione F; Matarese G; Salvatore F; Sacchetti L
Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639088
[TBL] [Abstract][Full Text] [Related]
19. Fusobacterium and colorectal cancer: causal factor or passenger? Results from a large colorectal cancer screening study.
Amitay EL; Werner S; Vital M; Pieper DH; Höfler D; Gierse IJ; Butt J; Balavarca Y; Cuk K; Brenner H
Carcinogenesis; 2017 Aug; 38(8):781-788. PubMed ID: 28582482
[TBL] [Abstract][Full Text] [Related]
20. Highly sensitive stool DNA testing of Fusobacterium nucleatum as a marker for detection of colorectal tumours in a Japanese population.
Suehiro Y; Sakai K; Nishioka M; Hashimoto S; Takami T; Higaki S; Shindo Y; Hazama S; Oka M; Nagano H; Sakaida I; Yamasaki T
Ann Clin Biochem; 2017 Jan; 54(1):86-91. PubMed ID: 27126270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
